Aimed Alliance Supports Creation of Rare Disease Council in Washington
Aimed Alliance provided a letter of support for the passage of Washington Senate Bill 5064,…
Browsing: State
Aimed Alliance Comments on Maryland PDAB Draft Rules
Aimed Alliance provided feedback on Maryland’s Prescription Drug Affordability Board’s draft regulations, COMAR 14.01.0 and…
Aimed Alliance Supports Increased Access to Biomarker Testing in Connecticut
Aimed Alliance submitted a letter of support for Connecticut House Bill 06771, which seeks to…
Survey Reveals Major Gaps in Workplace Support for Women’s Midlife Health Needs
WASHINGTON, DC / ACCESS Newswire / February 28, 2025 / New survey findings released today reveal significant gaps…
Aimed Alliance Urges Virginia to Reconsider PDAB Bill
On January 24, 2025, Aimed Alliance submitted a comment to the Virginia House Appropriations –…
Aimed Alliance Releases New Resource On New York’s 2024 Step Therapy Law
At the end of 2024, Governor Kathy Hochul signed Senate Bill 1267A/Assembly Bill A901A which…
Survey Finds 30% of Independent Pharmacies Will Not Stock Certain IRA-Negotiated Drugs
New data released by the National Community Pharmacists Association (NCPA) finds that roughly 30 percent…
Aimed Alliance Pushes for Transparency in AI Prior Authorization Decisions
Aimed Alliance submitted written testimony regarding Washington’s Senate Bill 5395 and House Bill 1566, which…
Aimed Alliance Advocates for Clarifications to WA Obesity Treatment Access Legislation
In February 2025, Aimed Alliance submitted a comment on Washington Senate Bill 5353, which would…
Aimed Alliance Urges Patient-Focused Amendments to MD PDAB Bill
Aimed Alliance provided comments on Maryland’s SB0357/HB0424, legislation that would enable the Maryland Prescription Drug…